U.S. stocks were bouncing back on Friday following a rough start to 2025. Markets opened higher, with the Dow up 200 points, as both the U.S. dollar and Treasury yields pulled back. Analysts have ...
Tourmaline Bio, Inc. (NASDAQ:TRML – Get Free Report) has been given a consensus rating of “Buy” by the six ratings firms that are covering the firm, MarketBeat Ratings reports. Six research analysts ...